Corporate venturing units Slack Fund and Gradient Ventures contributed to a series B round that increased the online whiteboard developer's total funding to about $143m.

Yumanity Therapeutics will take over Nasdaq-listed Proteostasis in a reverse merger after raising more than $100m from investors including Biogen, Merck & Co, Pfizer and Sanofi.

UT Dallas spinout Cersci Therapeutics has been acquired in a deal potentially worth nearly $940m, including a $52.5m upfront payment.

The database software provider advanced its valuation past the $1bn mark in a round featuring returning backer Dell Technologies Capital.

Gastrointestinal and liver disease-focused Metacrine has filed to go public having raised $125m from investors including Eli Lilly.

The chronic disease management platform has raised $34.7m in a round led by Bayer, which is also supplying up to $64m in development and milestone payments.

Hyatt, Sotheby’s, Digital Garage, American Express and Advance Publications exited experience marketplace IfOnly in an acquistion by fellow investor Mastercard in January.

CRM forecasting software provider Node has been purchased having raised $37m from investors including MS&AD Insurance, Gree, Recruit and JetBlue.

Juniper Networks has exited wireless communications technology developer Fastback in a $14m acquisition that follows at least $55m in funding.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.